GIVEHOPE, BSI Engineering Provide Support for Pancreatic Cancer Research
Thanks to funding support from GIVEHOPE and BSI Engineering,
Inc., scientists at the University of Cincinnati (UC) Cancer
Institute can continue research that could help in the discovery of
better treatments for patients with pancreatic cancer.
Since November 2011, the two organizations have fundraised
over $315,000 and endowed over $50,000 for future pancreatic cancer
research at the UC Cancer Institute.
Two additional checks from these organizations, in the amount
of $50,000 each, were gifted to the UC Cancer Institute’s
Pancreatic Cancer Center Feb. 18 during the institute’s
Pancreatic Patient Symposium.
"GIVEHOPE has done more to advance the awareness and research
for pancreas cancer in Cincinnati than any other
organization,” says Syed Ahmad, MD, professor in the
Department of Surgery, director of the Division of Surgical
Oncology at the UC College of Medicine; UC Health surgical
oncologist; and director of the Gastrointestinal Center and the
Pancreatic Disease Center at the UC Cancer Institute. "They remain
a close partner in our fight to improve the care and outcomes for
patients with pancreas cancer.”
Seed funding from community organizations like these has
helped researchers like Vladimir Bogdanov, PhD, assistant professor
and director of the Hemostasis Research Program in the Division of
Hematology Oncology, Department of Internal Medicine at the UC
College of Medicine, secure federal support to continue his studies
of a novel therapeutic target for certain pancreatic cancer
Bogdanov, a member at the UC Cancer Institute and the
Cincinnati Cancer Consortium, conducts research focused on a novel
form of Tissue Factor, the protein that starts the process of blood
clotting, known as alternatively-spliced Tissue Factor (asTF). His
studies have focused on effects of asTF on tumor growth and spread
of pancreatic cancer.
Bogdanov, who has received a number of gifts from GIVEHOPE and
BSI Engineering, Inc. over the years, says this funding is key in
helping him continue work his laboratory while waiting for the
federal funds to be awarded.
"In 2012, GIVEHOPE’s grants have been instrumental for
my lab in securing a larger, two-year exploratory grants from the
National Cancer Institute,” he says, adding that in 2015, he
received a 5-year, $1.4 million grant from the National Cancer
Institute. "When researchers are between grants, the work must
continue somehow. These types of grants make it possible. They can
even be our lifelines, sometimes.
"I am incredibly grateful to GIVEHOPE and BSI because their
grants will help my lab continue its research that will hopefully
lead to the discovery of more effective diagnostic and therapeutic
approaches to fight pancreatic cancer.”
Back to News